Pilot Randomised Trial of Calibrated Formula Volumes to Optimise Growth in Infants at Risk for Overweight: The Califormula Randomised Clinical Trial
Pediatric Obesity · 2026
DOI: 10.1111/ijpo.70141 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Obesity, 2026. Verfasst von Ian M Paul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Penn State College of Medicine, Hershey, Pennsylvania, USA. Hauptthemen laut MEDLINE: Infant Formula, Weight Gain, Pediatric Obesity, Overweight. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NCATS NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Background
Formula feeding and having a mother with overweight are associated with overweight during infancy.
Objectives
We sought to pilot test calibrated formula feeding guidance using age and weight specific intake recommendations to improve weight outcomes amongst at‐risk infants.
Methods
Exclusively formula fed newborns with birthweight ≥ 50th percentile delivered to mothers with pre‐pregnancy body mass index (BMI) ≥ 25 kg/m 2 were randomised to intervention and usual care groups. At monthly visits from 1 to 5 months, mothers of intervention group infants with weight‐for‐length (WFL) ≥ 75th percentile were advised to give 10% less daily formula than required based upon sex, age and weight. The primary outcome was conditional weight gain (CWG) between birth and 6 months. Secondary outcomes included WFL z ‐score and overweight (WFL ≥ 95th percentile) at 6 months, as well as growth trajectory.
Results
Sixty infants were enrolled; 36 mothers (66.7%) had pre‐pregnancy BMI ≥ 30. Seventeen (28.3%) withdrew before 6 months. At each assessment, a minority had WFL ≥ 75th percentile required to receive calibrated formula guidance. There were no group differences in CWG (intervention mean 0.27, 95% CI −0.20 to 0.75 vs. control mean −0.12, 95% CI −0.62 to 0.37; p = 0.25) or for secondary outcomes.
Conclusions
Calibrated infant formula recommendations were not associated with growth outcomes. Trial Registration: Clinicaltrials.gov identifier: NCT05104073 (registered October 11, 2021)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Penn State College of Medicine, Hershey, Pennsylvania, USA.
- School of Medicine, Universidade Federal de Pelotas, Pelotas, Brazil.
- The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
ORCID-Profile: Ian M Paul, Bernardo L Horta, Mina Desai
Förderung
- NICHD NIH HHS
- NCATS NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Center for Advancing Translational Sciences
Zitieren
APA
Paul, I. M., Horta, B. L., Desai, M., & Ross, M. G. (2026). Pilot Randomised Trial of Calibrated Formula Volumes to Optimise Growth in Infants at Risk for Overweight: The Califormula Randomised Clinical Trial. Pediatric Obesity. https://doi.org/10.1111/ijpo.70141
Vancouver
Paul IM, Horta BL, Desai M, Ross MG. Pilot Randomised Trial of Calibrated Formula Volumes to Optimise Growth in Infants at Risk for Overweight: The Califormula Randomised Clinical Trial. Pediatric Obesity. 2026. doi:10.1111/ijpo.70141
BibTeX
@article{Paul2026,
author = {Paul, Ian M and Horta, Bernardo L and Desai, Mina and Ross, Michael G},
title = {Pilot Randomised Trial of Calibrated Formula Volumes to Optimise Growth in Infants at Risk for Overweight: The Califormula Randomised Clinical Trial},
journal = {Pediatric Obesity},
year = {2026},
doi = {10.1111/ijpo.70141}
}
EUVIMED